A Clinical Trial Evaluating the Safety and Efficacy of Intravenous HNF4α SrRNA in Treating Metastatic CRC Patients

NCT06621173 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Colorectal Cancer (mCRC)

Interventions

DRUG: HNF4α srRNA

Sponsor

Shanghai Changzheng Hospital